Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...

Insulet Corporation (NASDAQ:PODD) showcases a high Return on Invested Capital (ROIC) of 16.28% and a Weighted Average Cost of ...

Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

In the bowl you used for the sweet potato and carrots, add the broccoli, red pepper, and chicken. Add the remaining 2 tbsp ...

Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...

Stifel Nicolaus analyst Mathew Blackman maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report) today and set a price target ...

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eighteen research firms that are presently covering the company ...

Tandem Diabetes Care Inc.’s Control-IQ+ automated insulin delivery system improved multiple measures of glycemic control in individuals with type 2 diabetes who use insulin, a study presented March 19 ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...